These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11118795)

  • 21. Favourable prognostic factors with infantile spasms.
    Riikonen RS
    Eur J Paediatr Neurol; 2010 Jan; 14(1):13-8. PubMed ID: 19362867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
    Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vigabatrin: new indication. An advance in infantile spasms.
    Prescrire Int; 1998 Apr; 7(34):43-4. PubMed ID: 10183381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seizure outcome in infantile spasms--a retrospective study.
    Mohamed BP; Scott RC; Desai N; Gutta P; Patil S
    Epilepsia; 2011 Apr; 52(4):746-52. PubMed ID: 21320111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vigabatrin in the treatment of infantile spasms].
    Backström M; Eriksson K; Koivikko M
    Duodecim; 1995; 111(9):853-5. PubMed ID: 8681848
    [No Abstract]   [Full Text] [Related]  

  • 28. Crisis Standard of Care: Management of Infantile Spasms during COVID-19.
    Grinspan ZM; Mytinger JR; Baumer FM; Ciliberto MA; Cohen BH; Dlugos DJ; Harini C; Hussain SA; Joshi SM; Keator CG; Knupp KG; McGoldrick PE; Nickels KC; Park JT; Pasupuleti A; Patel AD; Pomeroy SL; Shahid AM; Shellhaas RA; Shrey DW; Singh RK; Wolf SM; Yozawitz EG; Yuskaitis CJ; Waugh JL; Pearl PL;
    Ann Neurol; 2020 Aug; 88(2):215-217. PubMed ID: 32445204
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of infantile spasms: an evidence-based approach.
    Mackay M; Weiss S; Snead OC
    Int Rev Neurobiol; 2002; 49():157-84. PubMed ID: 12040891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
    van der Poest Clement EA; Sahin M; Peters JM
    J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
    Wohlrab G; Leiba H; Kästle R; Ramelli G; Schmitt-Mechelke T; Schmitt B; Landau K
    Epilepsia; 2009 Aug; 50(8):2006-8. PubMed ID: 19682036
    [No Abstract]   [Full Text] [Related]  

  • 32. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
    Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
    Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigabatrin-related magnetic resonance imaging abnormalities in an infant with tuberous sclerosis complex and infantile spasms.
    Hsieh DT; Thiele EA
    J Pediatr; 2013 Jan; 162(1):215. PubMed ID: 22979977
    [No Abstract]   [Full Text] [Related]  

  • 35. Vigabatrin for tuberous sclerosis complex.
    Curatolo P; Verdecchia M; Bombardieri R
    Brain Dev; 2001 Nov; 23(7):649-53. PubMed ID: 11701271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vigabatrin Toxicity in a Patient with Infantile Spasms Treated with Concomitant Hormonal Therapy.
    Lotan E; Bluvstein J; Zan E
    Isr Med Assoc J; 2020 Jul; 22(7):461-462. PubMed ID: 33236576
    [No Abstract]   [Full Text] [Related]  

  • 37. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
    Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
    Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infantile spasms: experience in 13 cases].
    Fonseca LF; Oliveira AL
    Arq Neuropsiquiatr; 2000 Jun; 58(2B):512-7. PubMed ID: 10920415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
    Jones K; Snead OC; Boyd J; Go C
    J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.